OPCs
OPCs, licence 80069336: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Grape Seed Extract 100 mg Softgel Capsule
- Licence holder
- MIHB Inc.
- NPN or DIN-HM
- 80069336
- Status
- Active licence
- Licence date
- 11 May 2016
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitis vinifera Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 2500 milligramme Potency : 95.0 % Oligomeric proanthocyanidins | 100.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Cire d'abeille jaune, Eau purifiée, Glycérine, Caramel, Lécithine, Huile de fève de soja, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Source of antioxidants for the maintenance of good health. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Relief of symptoms related to non-complicated CVI: Consult a health care practitioner if symptoms worsen.
Source
Official Health Canada record, licence 80069336
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.